Immuta
PrivateLast Round
Strategic
May 4, 2023
Est. Valuation
$1B
Total Funding Raised
$259.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Immuta operates in AI, Data & Cloud Infrastructure and is based in Boston, Massachusetts. Its latest recorded funding round was a Strategic round in May 2023.
Immuta is a data security and governance company that provides a cloud-native platform to automate data access, discovery, and monitoring for enterprises.
Sector
AI, Data & Cloud Infrastructure
Verticals
Data Governance, Cloud Security, Data Protection, Compliance & Risk
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Price History
Caplight MarketPrice™ estimate for Immuta, published with a 90-day delay.
Caplight MarketPrice™
$13.31
per share, as of July 2026
-10.7%
7-month change
The most recent months of MarketPrice™ are available to Caplight clients.
Caplight MarketPrice™ is an estimate of private secondary market pricing, shown here on a delayed basis for illustrative purposes only. It may be incomplete, is subject to change, and may not be relied upon for any purpose or considered investment advice.
Immuta Comparables
Compare Immuta with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Privacera | 91% | |
| SecuPi | 82% | |
| Commvault Systems, Inc. | 80% |
For institutional investors. Book with your work email.
Immuta Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 4, 2023 | ||||
| Series E | Jun 8, 2022 | ||||
| Series D | May 20, 2021 | ||||
| Series C | Jun 23, 2020 | ||||
| Series B | Jun 19, 2018 | ||||
Series A | Feb 16, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Immuta Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NightDragon | Series E |
| Citi Ventures | Series B, Series D, Series C |
| Okta Ventures | Series D |
| StepStone Group | Series D |
| Snowflake Ventures | Series E |
| Madison Ventures | Series B |
| Ten Eleven Ventures | Series E, Series D, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Recognized by Fast Company as a top 50 most innovative company.
- Jul 1, 2026
Cited by BuiltIn as one of the best workplaces.
For institutional investors. Book with your work email.
Immuta Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Immuta's valuation, stock price, and market status.
Is Immuta a public or private company?
Immuta is a private company.
What is the current stock price of Immuta?
Immuta is a private company, so its shares have no public market price. Caplight tracks Immuta's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Immuta worth (valuation)?
Immuta's valuation is estimated at $1.0B based on funding round data.
Can I buy Immuta stock?
Immuta shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Immuta's last funding round?
Immuta's most recent funding round was Strategic on May 4, 2023.
Who are the main investors in Immuta?
Key investors in Immuta include NightDragon, StepStone Group, Intel Capital, DFJ Growth, Blu Venture Investors.
Will Immuta IPO soon?
No public IPO plans have been announced for Immuta.
How can I track Immuta secondary market activity?
Caplight tracks bids, offers, and trades in Immuta's shares on secondary markets.